• Home
  • NEW DAY MEDICINE
  • 4 (78) 2025
  • 29 -4 (78) 2025 - Nurkhanova N.О. - VITAMIN D LEVEL AND METABOLIC DISORDERS IN PATIENTS WITH ENDOMETRIAL HYPERPLASIA IN THE PERIMENOPAUSAL PERIOD

29 -4 (78) 2025 - Nurkhanova N.О. - VITAMIN D LEVEL AND METABOLIC DISORDERS IN PATIENTS WITH ENDOMETRIAL HYPERPLASIA IN THE PERIMENOPAUSAL PERIOD

VITAMIN D LEVEL AND METABOLIC DISORDERS IN PATIENTS WITH ENDOMETRIAL HYPERPLASIA IN THE PERIMENOPAUSAL PERIOD

Nurkhanova N.О. - Bukhara State Medical Institute named after Abu Ali ibn Sina

Resume

Currently, proliferative diseases of the endometrium are a known background for the development of endometrial cancer. In this regard, improving diagnostics, studying additional risk factors and predictors of endometrial hyperplasia, as well as methods for preventing this disease are important aspects of the prevention of cancer. This article presents our own results of the research.

Keywords: perimenopause, endometrial hyperplasia, obesity, vitamin D.

First page

172

Last page

177

For citation:Nurkhanova N.О. - VITAMIN D LEVEL AND METABOLIC DISORDERS IN PATIENTS WITH ENDOMETRIAL HYPERPLASIA IN THE PERIMENOPAUSAL PERIOD//New Day in Medicine 4(78)2025 172-177 https://newdayworldmedicine.com/en/new_day_medicine/4-78-2025

List of References

  1. Дубровина С.О. Патогенетические аспекты гиперпластических процессов в эндометрии у женщин с метаболическим синдромом / С.О. Дубровина, Н.Х. Скачков, Ю.Д. Берлим и др. // Росс, Вестн. акушер-гинеколог. 2008;3:41-44.
  2. Бочкарева Н.В., Кондакова И.В., Коломиц Л.А., Чернышова А.Л. Роль инсулиноподобных факторов роста и их связывающих белков в патогенезе и прогнозе рака эндометрия // Российский журнал онкологии, 2009;3:46-50.
  3. Давыдов А.И. Атипичная гиперплазия эндометрия: вопросы морфогенеза, классификации, диагностики и лечения / А.И. Давыдов, О.В. Крыжановская // Вып. 2009;8(3):93-96.
  4. Зарипова Д.Я., Туксанова Д.И., Негматуллаева М.Н. Особенности перименопаузального перехода у женщин с ожирением. // Новости дерматовенерологии и репродуктивного здоровья. 2020;1-2:39-42.
  5. Зарипова Д.Я., Абдуллаева М.А., Султонова Н.А., Ахмедов Ф.К., Насирова З.С., Умуров Э.У., Шукруллаева Г.Ж. Оптимизация мер диагностики ранней менопаузы и преждевременной менопаузы. // Репродуктивное здоровье восточная Европа. 2024;14(5):617-628.
  6. Kurman R.J., Kaminski P.F., Norris H.J. The behavior of endometrial hyperplasia. A long-term study of “untreated” hyperplasia in 170 patients. Cancer. 2015;56:403-12. [PubMed] [Google Scholar]
  7. Nurkhanova N.O. Assessment of the risk of endometrial hyperplasia in the perimenopausal period. / International Journal of Advanced Research in Engineering and Applied Sciences, 2022;11(6):8-15. https://garph.co.uk/IJAREAS/June2022/2.pdf
  8. Tavassoli FA. World Health Organization Classification of Tumors: Pathology and Genetics of Tumors of the Breast and Female Genital Organs. Lyon: IARC Press; 2013. [Google Scholar]
  9. Ries LAG, Melbert D, Krapcho M, Stinchcomb DG, Howlander MJ, Horner MJ, et al. Finding Cancer Statistics. Cancer Stat Fact Sheets, Cancer of the Corpus and Uterus, NOS. National Cancer Institute; Bethesda, MD: 2008;3(31–0008. http://seer.cancer.gov/statfacts/html/corp.html. [Google Scholar]
  10. Shapiro AG. Emergency treatment of menstrual disorders in a nonpregnant woman. Emerg Med Clin North Am. 2017;5:559–68. [PubMed] [Google Scholar]
  11. Prip C.M., Stentebjerg M., Bennetsen M.H., Petersen L.K., Bor P. Risk of atypical hyperplasia and endometrial carcinoma after initial diagnosis of non-atypical endometrial hyperplasia: A long-term follow-up study // PLoS ONE. 2022;17(4). Art. ID: e0266339. https://doi.org/10.1371/journal.pone.0266339
  12. Henn M., Martin-Gorgojo V., Martin-Moreno J.M. Vitamin D in cancer prevention: Gaps in current knowledge and room for hope // Nutrients. 2022;14(21):4512. DOI: https://doi.org/10.3390/nu14214512

    file

    download